JAMES ROBERTSON: Open Payments
NPI 1962768481 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 21 payments from 8 companies in 2025. Trend: 2023 $82 · 2024 $398 · 2025 $399
Food & beverage: $394Education: $5
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $103 |
| Mallinckrodt Hospital Products Inc. | 4 | $80 |
| Ardelyx, Inc. | 3 | $72 |
| Travere Therapeutics, Inc. | 4 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: FARXIGA, IBSRELA, ACTHAR, Kerendia, Filspari, TERLIVAZ, JYNARQUE, Veltassa.
Industry payments across VA — which companies pay providers there.
